SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,621,191 | -4.6% | 458,845 | -9.8% | 0.10% | -2.9% |
Q2 2023 | $58,272,929 | -40.7% | 508,845 | -28.6% | 0.10% | -52.8% |
Q1 2023 | $98,249,910 | +12.6% | 712,834 | +5.8% | 0.22% | -35.9% |
Q4 2022 | $87,286,643 | -35.9% | 673,612 | -45.3% | 0.34% | -23.4% |
Q3 2022 | $136,119,000 | +57.0% | 1,231,396 | +6.5% | 0.44% | +88.8% |
Q2 2022 | $86,684,000 | -5.6% | 1,156,396 | -1.6% | 0.23% | +26.6% |
Q1 2022 | $91,853,000 | -6.8% | 1,175,796 | +7.4% | 0.18% | +0.5% |
Q4 2021 | $98,605,000 | +1098.1% | 1,095,000 | +1130.3% | 0.18% | +1207.1% |
Q3 2021 | $8,230,000 | +218.9% | 89,000 | +345.0% | 0.01% | +40.0% |
Q4 2019 | $2,581,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |